Introduction to Gene Therapy Manufacturing
Overview
This 2.5-day course at NIBRT provides essential knowledge of Gene Therapy manufacturing processes for safe, effective production and regulatory approval. Held at NIBRT’s advanced therapy training facility, the course offers hands-on experience with the latest technologies for GMP manufacturing of gene therapies.
NIBRT equipment includes:
- Adherent cell culture, scale-up to fixed bed or single-use suspension bioreactors, harvest, single-use chromatography, ultrafiltration/diafiltration systems, and cryopreservation.
Lectures will cover technologies, processes, and regulatory considerations for gene therapy manufacturing, ensuring participants are well-prepared for gene therapy production. For more specialised training on a specific modality, explore our specialised courses which are available on request.
Key topics covered
- Regulatory landscape
- Gene Therapy Delivery Systems
- Gene Therapy Manufacturing Platforms – Viral Vectors, Non-Viral Vectors
- Process Scale-Up and Challenges
- Quality Control of Gene Therapies
Who should attend
Operators will gain valuable hands-on experience with practical. The course’s interactive approach ensures that they can confidently apply these skills in real-world settings, improving their proficiency and troubleshooting capabilities.
Scientists and Senior Management will benefit from the visualization of complex theories and processes, bridging the gap between technical knowledge and operational practices. By seeing the theory in action, they will gain a deeper understanding of critical systems, enabling them to make more informed decisions and optimize their departments’ performance.
What do Attendees Obtain on Completion?
A competency-based assessment will be taken at the end of the course. Attendees will receive a certificate of attendance.
Register
Course Format
Onsite Training at NIBRT
- 2.5 days onsite training at NIBRT facility
Dates & Price
Dates:
- Course 1 08/10/2025 - 10/10/2025
NIBRT Onsite Course
€2,490.006 Places Remaining
